The Toll-like receptors and their role in septic shock

Bibliography

• BONE RC, BALK RA, CERRA FB et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest (1992) 101:1644–1655.
   PubMed Web of Science ®Google Scholar
• STEIN D, ROTH S, VOGELSANG E, NUSSLEIN-VOLHARD C: The polarity of the dorsoventral axis in the Drosophila embryo is defined by an extracellular signal. Cell (1991) 65:725–735.
   PubMed Web of Science ®Google Scholar
• HOFFMAN JA, REICHHART JM: Drosophila immunity. Trends Cell Biol. (1997) 7:309–316.
   PubMed Web of Science ®Google Scholar
• JANE WAY CA Jr, MEDZHITOV R: Innate immune recognition. Annu. Rev Immunol. (2002) 20:197–216.
   PubMed Web of Science ®Google Scholar
• •An excellent review of the role of TLRs in inducing the host innate immune response, describing decades of research in the important field of innate immune recognition.
   Google Scholar
• HOFFMAN JA, KAFATOS FC, JANEWAY CA, EZEKOWITZ RAB: Phylogenetic perspectives in innate immunity. Science (1999) 284:1313–1317.
   PubMed Web of Science ®Google Scholar
• MEANS TK, GOLENBOCK DT, FENTON MJ: The biology of Toll-like receptors. Cytokine Growth Factor Rev (2000) 11:219–232.
   PubMed Web of Science ®Google Scholar
• WHITHAM S, DINESH-KUMAR SP, CHOI D, HEHL R, CORR C, BAKER B: The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor. Cell (1994) 78:1101–1115.
   PubMed Web of Science ®Google Scholar
• OPAL SM, HUBER CE: Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit. Care (2002) 6:125–136.
   PubMed Web of Science ®Google Scholar
• KADOWSKI N, HO S, ANTONENKO S et al.: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. (2001) 194:863–869.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that different cell lines of the innate immune response express differential levels of the TLRs on their cell surface. This indicates that different subsets of antigen-presenting cells recognise different pattern recognition molecules expressed on microbial pathogens.
   Google Scholar
• LIEN E, SELLATI TJ, YOSHIMURA A et al.: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. (1999) 274:33419–33425.
   PubMed Web of Science ®Google Scholar
• SIERADZKI K, ROBERTS RB, HABER SW, TOMASZ A: The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. (1999) 340:517–523.
   PubMed Web of Science ®Google Scholar
• RENTZ AM, HALPERN MT, BOWDEN R: The impact of candidemia on length of stay, outcome and overall cost of illness. Clin. Infect. Dis. (1998) 27:781–788.
   PubMed Web of Science ®Google Scholar
• ALEXOPOULOU L, HOLT AC, MEDZHITOV R, FLAVELL RA: Recognition of double stranded RNA and activation of NFicB by toll-like receptor 3. Nature (2001) 413:732–738.
   PubMed Web of Science ®Google Scholar
• OSHIUMI H, MATSUMOTO M, FUNAMI K, AKAZAWA T, SEYA T: TICAM-1, an adapter molecule that participates in Toll-like receptor 3-mediated interferon-I3 induction. Nat. Immunol. (2003) 4:161–167.
   PubMed Web of Science ®Google Scholar
• ••Describes an intracellular adaptor moleculethat recognises the TIR domain expressed on TLR3 and 4. This molecule, known as TICAM or TRIF, links intracellular signalling between bacterial and viral antigens.
   Google Scholar
• YAMAMOTO M, SATO S, MORI K et al.: Cutting edge: a novel To1l/IL-1 receptor domain-containing adapter that preferentially activates the IFN-I3 promoter in the Toll-like receptor signaling. .1. Immunol. (2002) 169:6668–6672.
   Google Scholar
• POLTORAK A, HE X, SMIRNOVA I et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science (1998) 282:2085–2088.
   PubMed Web of Science ®Google Scholar
• VIRIYAKOSOL S, TOBIAS PS, KITCHENS RL, KIRKLAND TN: MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. (2001) 276:38044–38051.
   PubMed Web of Science ®Google Scholar
• OGATA H, SU I, MIYAKE K et al.: The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. (2000) 192:23–29.
   PubMed Web of Science ®Google Scholar
• MEDZHITOV R, PRESTO-HURLBURT p, KOPP E et al: MyD88 is an adapter protein in the hToll/IL-1 receptor signaling pathways. Mol. Cell (1998) 2:253–258.
   PubMed Web of Science ®Google Scholar
• KAWAI T, TAKEUCHI O, FUJITA T et al.: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. Immunol. (2001) 167(10): 5887–5894.
   Web of Science ®Google Scholar
• •This investigation demonstrates that LPS has a MyD88-independent pathway of cellular activation after engagement of LPS to the TLR4 and MD-2 complex.
   Google Scholar
• LYNN M, ROSSIGNOL DR, WHEELER J et al: Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J. Infect. Dis. (2003) 187:631–639.
   PubMed Web of Science ®Google Scholar
• HAYASHI F, SMITH KD, OZINSKY A et al: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature (2001) 420:1099–1103.
   Google Scholar
• •This paper first describes the importance of TLR5 in the recognition of bacterial flagellin.
   Google Scholar
• JURK M, VOLLMER J, SCHETTER C et al: Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. (2002) 3:196–200.
   PubMed Web of Science ®Google Scholar
• HORNUNG V, ROTHENFUSSER S, BRITSCH S et al: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. j. brununol. (2002) 168:4531–4537.
   Google Scholar
• KREIG AM: Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Blochim Biophys. Acta (1999) 1489:107–116.
   PubMedGoogle Scholar
• SPARWASSER T, MIETHKE T, LIPFORD G et al.: Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-a-mediated shock. Eur. brununol. (1997) 27:1671–1674.
   PubMed Web of Science ®Google Scholar
• BAUER S, KIRSCHNING CJ, HACKER H et al.: Human TLR9 confers responsiveness to bacterial DNA via specific CpG motif recognition. Proc. Natl Acad. Sci. USA (2001) 98:9237–9242.
   PubMed Web of Science ®Google Scholar
• •Describes the importance of unmethylated CpG motifs found in bacterial DNA as the pattern recognition molecule recognised by human TLR9.
   Google Scholar
• HEMMI H, TAKEUCHI O, KAWAI T et al: A Toll-like receptor recognizes bacterial DNA. Nature (2000) 408:740–744.
   PubMed Web of Science ®Google Scholar
• GAO JJ, XUE Q, PAPASIAN CJ, MORRISON DC: Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-a through apost-transcriptional mechanism. konunol. (2001) 166:6855–6860.
   Google Scholar
• •Describes the synergistic activity of TLR9 and 4 ligands in the activation of intracellular signalling of human effector cells. In actual infections, multiple TLR molecules are activated by multiple different pattern recognition molecules expressed on microbial pathogens.
   Google Scholar
• HALPERIN S, VAN NEST G, SMITH B, ABTAHI S, WHILEY H, EIDEN J: A Phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine (2003) 21:2461–2467.
   PubMed Web of Science ®Google Scholar
• WEIGHARDT H, FETEROWSKI C, VEIT M, RUMP M, WAGNER H, HOLZMANN B: Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. konunol. (2000) 165:4537–4543.
   Google Scholar
• ••Describes the potential therapeutic utilityof CpG motifs found on bacterial DNA as a potential immunostimulatory pathway of innate immune activation.
   Google Scholar
• CHUANG T, ULEVITCH RJ: Identificationof hTLR10: a novel toll-like receptor preferentially expressed in immune cells. Blochim Biophys. Acta (2001) 1518:157–161.
   PubMed Web of Science ®Google Scholar
• WAMI K, MATSUGUCHI T, MASADA A, KIKUCHI T, MUSIKACHAROEN T, YOSHIKAI Y: Cutting edge: naturally occurring soluble form of mouse toll like receptor 4 inhibits lipopolysaccharide signaling. konunol. (2001) 165:6682–6686.
   Google Scholar
• OPALS, PALARDY J, PAREJO N, JASMAN R: Effect of anti-CD14 monoclonal antibody on clearance of Escherichia colibacteremia and endotoxemia. Grit. Care Med. (2003) 31:929–932.
   PubMed Web of Science ®Google Scholar
• BEUTLER B: Science review: key inflammatory and stress pathways in critical illness — the central role of the Toll-like receptor. Crit. Care (2003) 7:39–46.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of the TLR pathwaysfound in the innate immune system and their importance in the pathogenesis of septic shock.
   Google Scholar